KB408 (Nebulization)
KB408-01
Phase 1 small_molecule active
Quick answer
KB408 (Nebulization) for Alpha 1-Antitrypsin Deficiency is a Phase 1 program (small_molecule) at Krystal Biotech with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Krystal Biotech
- Indication
- Alpha 1-Antitrypsin Deficiency
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active